Clinical Trial Update: Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy, safety, and immunogenicity of adalimumab compared with Humira in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Humira (adalimumab)

Snippet

Sponsor: Mabscale, LLC | Conditions: Plaque Psoriasis | Phase 3 | Status: UNKNOWN